Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Hematopoietic and Lymphatic System Neoplasm 8Breast Neoplasms 8Lung Neoplasms 5Prostatic Neoplasms 4Malignant Solid Neoplasm 4Colorectal Neoplasms 4Ovarian Neoplasms 3Hematologic Neoplasms 3Thyroid Cancer, Papillary 2Oropharyngeal Neoplasms 2Neoplasms 2Multiple Myeloma 2Mouth Neoplasms 2Melanoma 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Head and Neck Neoplasms 2Depression 2Colonic Neoplasms 2Carcinoma 2Anatomic Stage I Breast Cancer AJCC v8 2Advanced Malignant Solid Neoplasm 2Adenocarcinoma, Follicular 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Smoking Cessation 1Sarcoma 1

Interventions

Specimen Handling 1Psilocybin 1Interviews as Topic 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Depressive Disorder × Interviews as Topic × 90 days × Clear all
NCT07216404 2026-05-14

Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Depressive Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡